We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Antithrombin ATryn From Genetically Altered Animals
FDA Approves Antithrombin ATryn From Genetically Altered Animals
February 13, 2009
The FDA approved GTC Biotherapeutics and Ovation Pharmaceuticals’ ATryn, the first therapeutic protein from genetically altered animals and the first recombinant antithrombin approved in the U.S.